Viveve Medical, Inc. (VIVE)
Price:
0.00 USD
( - 0 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Koninklijke Philips N.V.
VALUE SCORE:
6
2nd position
Embla Medical hf.
VALUE SCORE:
10
The best
Drägerwerk AG & Co. KGaA
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
No data to display
No data to display
DESCRIPTION
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
NEWS
SURMOUNT Advises VIVE Collision on Sale-Leaseback Portfolio Transaction with Four Corners Property Trust
businesswire.com
2025-06-20 12:08:00NEW YORK--(BUSINESS WIRE)--SURMOUNT, a leading full-service net lease real estate advisory and investment platform, is proud to announce that it served as the exclusive real estate advisor to VIVE Collision in the successful sale-leaseback of a portfolio of automotive service properties to Four Corners Property Trust (NYSE:FCPT) for $4.7 million. This portfolio includes well‑located facilities in prime retail corridors across Maine and Vermont, all leased back under triple‑net leases with 20 ye.
Mynd Immersive, Select Rehabilitation, HTC VIVE, and AT&T Expand Next Generation of Immersive Therapeutics to More Than 150 U.S. Senior Living Communities
businesswire.com
2025-04-01 08:00:00ATLANTA--(BUSINESS WIRE)--Mynd Immersive, the industry leader in immersive healthcare solutions for older adults, successfully concluded Q1 by expanding its digital health footprint with the addition of 150 senior living communities across the United States. This milestone represents the largest deployment of Extended Reality (XR) therapies in senior care history, significantly advancing innovative treatment options across physical, occupational, and speech therapy. “We envisioned early on that.
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
investorplace.com
2023-01-17 08:43:42Viveve Medical (NASDAQ: VIVE ) stock is falling hard on Tuesday after releasing results from the company's latest clinical trial. That trial covers the use of the Viveve treatment for women suffering from stress urinary incontinence.
Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript
seekingalpha.com
2022-11-10 21:25:04Viveve Medical, Inc. (NASDAQ:VIVE ) Q3 2022 Results Conference Call November 10, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Scott Durbin - CEO Jim Robbins - SVP, Finance and Administration Operator Good afternoon. Welcome to the Viveve Third Quarter 2022 Financial Results and Corporate Update Conference Call.
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
accesswire.com
2022-10-27 08:28:00ENGLEWOOD, CO / ACCESSWIRE / October 27, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its third quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 10, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-08-11 18:38:04Viveve Medical, Inc. (NASDAQ:VIVE ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - SVP, Finance and Administration Scott Durbin - CEO Conference Call Participants Operator Good afternoon, and welcome to the Viveve Second Quarter 2022 Financial Results and Corporate Update Conference Call. [Operator Instructions] Please note, this event is being recorded.
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
accesswire.com
2022-07-28 16:28:00ENGLEWOOD, CO / ACCESSWIRE / July 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its second quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 11, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Viveve to Participate in H.C. Wainwright Global Investment Conference
accesswire.com
2022-05-17 16:28:00ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright Global Investment Conference, May 23 - 26, 2022.
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-05-12 21:06:01Viveve Medical, Inc. (NASDAQ:VIVE ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - Senior Vice President, Finance and Administration Scott Durbin - Chief Executive Officer Conference Call Participants Operator Good afternoon, and welcome to the Viveve First Quarter 2022 Financial Results and Corporate Update Conference Call. All participants will be in a listen-only mode.
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
accesswire.com
2022-04-28 08:28:00ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, May 12, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com
2022-03-17 19:44:05Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
seekingalpha.com
2021-11-11 20:45:27Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
Viveve to Host Conference Call on November 11, 2021 to Report Third Quarter Financial Results and Provide Corporate Update
accesswire.com
2021-11-02 08:28:00ENGLEWOOD, CO / ACCESSWIRE / November 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its third quarter 2021 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 11, 2021. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
pennystocks.com
2021-09-20 14:30:00Biotech penny stocks are heating up right now, here's three to watch The post Are Biotech Penny Stocks Worth Buying? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
accesswire.com
2021-09-07 08:28:00ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 - 15, 2021.
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript
seekingalpha.com
2021-08-12 20:50:07Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript
No data to display
SURMOUNT Advises VIVE Collision on Sale-Leaseback Portfolio Transaction with Four Corners Property Trust
businesswire.com
2025-06-20 12:08:00NEW YORK--(BUSINESS WIRE)--SURMOUNT, a leading full-service net lease real estate advisory and investment platform, is proud to announce that it served as the exclusive real estate advisor to VIVE Collision in the successful sale-leaseback of a portfolio of automotive service properties to Four Corners Property Trust (NYSE:FCPT) for $4.7 million. This portfolio includes well‑located facilities in prime retail corridors across Maine and Vermont, all leased back under triple‑net leases with 20 ye.
Mynd Immersive, Select Rehabilitation, HTC VIVE, and AT&T Expand Next Generation of Immersive Therapeutics to More Than 150 U.S. Senior Living Communities
businesswire.com
2025-04-01 08:00:00ATLANTA--(BUSINESS WIRE)--Mynd Immersive, the industry leader in immersive healthcare solutions for older adults, successfully concluded Q1 by expanding its digital health footprint with the addition of 150 senior living communities across the United States. This milestone represents the largest deployment of Extended Reality (XR) therapies in senior care history, significantly advancing innovative treatment options across physical, occupational, and speech therapy. “We envisioned early on that.
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
investorplace.com
2023-01-17 08:43:42Viveve Medical (NASDAQ: VIVE ) stock is falling hard on Tuesday after releasing results from the company's latest clinical trial. That trial covers the use of the Viveve treatment for women suffering from stress urinary incontinence.
Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript
seekingalpha.com
2022-11-10 21:25:04Viveve Medical, Inc. (NASDAQ:VIVE ) Q3 2022 Results Conference Call November 10, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Scott Durbin - CEO Jim Robbins - SVP, Finance and Administration Operator Good afternoon. Welcome to the Viveve Third Quarter 2022 Financial Results and Corporate Update Conference Call.
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
accesswire.com
2022-10-27 08:28:00ENGLEWOOD, CO / ACCESSWIRE / October 27, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its third quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 10, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-08-11 18:38:04Viveve Medical, Inc. (NASDAQ:VIVE ) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - SVP, Finance and Administration Scott Durbin - CEO Conference Call Participants Operator Good afternoon, and welcome to the Viveve Second Quarter 2022 Financial Results and Corporate Update Conference Call. [Operator Instructions] Please note, this event is being recorded.
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
accesswire.com
2022-07-28 16:28:00ENGLEWOOD, CO / ACCESSWIRE / July 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its second quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 11, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Viveve to Participate in H.C. Wainwright Global Investment Conference
accesswire.com
2022-05-17 16:28:00ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright Global Investment Conference, May 23 - 26, 2022.
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com
2022-05-12 21:06:01Viveve Medical, Inc. (NASDAQ:VIVE ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim Robbins - Senior Vice President, Finance and Administration Scott Durbin - Chief Executive Officer Conference Call Participants Operator Good afternoon, and welcome to the Viveve First Quarter 2022 Financial Results and Corporate Update Conference Call. All participants will be in a listen-only mode.
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
accesswire.com
2022-04-28 08:28:00ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its first quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, May 12, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript
seekingalpha.com
2022-03-17 19:44:05Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
seekingalpha.com
2021-11-11 20:45:27Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
Viveve to Host Conference Call on November 11, 2021 to Report Third Quarter Financial Results and Provide Corporate Update
accesswire.com
2021-11-02 08:28:00ENGLEWOOD, CO / ACCESSWIRE / November 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that it will report its third quarter 2021 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, November 11, 2021. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
pennystocks.com
2021-09-20 14:30:00Biotech penny stocks are heating up right now, here's three to watch The post Are Biotech Penny Stocks Worth Buying? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
accesswire.com
2021-09-07 08:28:00ENGLEWOOD, CO / ACCESSWIRE / September 7, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 - 15, 2021.
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript
seekingalpha.com
2021-08-12 20:50:07Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript